AADACL4

gene
On this page

Also known as OTTHUMG00000001889

Summary

AADACL4 (arylacetamide deacetylase like 4, HGNC:32038) is a protein-coding gene on chromosome 1p36.21, encoding Arylacetamide deacetylase-like 4 (Q5VUY2).

Predicted to enable carboxylic ester hydrolase activity. Predicted to be located in membrane.

Source: NCBI Gene 343066 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 79 total — 1 pathogenic
  • MANE Select transcript: NM_001013630

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:32038
Approved symbolAADACL4
Namearylacetamide deacetylase like 4
Location1p36.21
Locus typegene with protein product
StatusApproved
AliasesOTTHUMG00000001889
Ensembl geneENSG00000204518
Ensembl biotypeprotein_coding
Entrez343066

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000376221

RefSeq mRNA: 1 — MANE Select: NM_001013630 NM_001013630

CCDS: CCDS30590

Canonical transcript exons

ENST00000376221 — 4 exons

ExonStartEnd
ENSE000013680201266596112667076
ENSE000013759091266179112661854
ENSE000013872051265112312651339
ENSE000014697771264408512644714

Expression profiles

Bgee: expression breadth broad, 47 present calls, max score 54.32.

Top tissues by expression

108 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
omental fat padUBERON:001041454.32gold quality
metanephros cortexUBERON:001053352.35gold quality
endometriumUBERON:000129548.60gold quality
adult mammalian kidneyUBERON:000008246.78gold quality
myometriumUBERON:000129645.43gold quality
placentaUBERON:000198745.03gold quality
smooth muscle tissueUBERON:000113544.99gold quality
endocervixUBERON:000045844.68gold quality
kidneyUBERON:000211344.21gold quality
body of uterusUBERON:000985343.64gold quality
lymph nodeUBERON:000002943.54gold quality
stromal cell of endometriumCL:000225543.34silver quality
left uterine tubeUBERON:000130343.33gold quality
muscle layer of sigmoid colonUBERON:003580543.23gold quality
vaginaUBERON:000099642.93gold quality
mucosa of transverse colonUBERON:000499142.84silver quality
cortex of kidneyUBERON:000122542.28gold quality
uterine cervixUBERON:000000241.59gold quality
colonic epitheliumUBERON:000039741.55gold quality
prostate glandUBERON:000236740.96gold quality
ectocervixUBERON:001224940.27gold quality
urinary bladderUBERON:000125539.95gold quality
muscle tissueUBERON:000238539.35gold quality
fallopian tubeUBERON:000388938.58gold quality
adipose tissueUBERON:000101338.40gold quality
skeletal muscle tissueUBERON:000113438.13gold quality
colonUBERON:000115537.79gold quality
right adrenal gland cortexUBERON:003582737.58silver quality
spleenUBERON:000210637.43gold quality
fundus of stomachUBERON:000116036.83gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.95

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

20 targeting AADACL4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4533100.0069.482758
HSA-MIR-4283100.0066.422097
HSA-MIR-512-3P99.9767.351049
HSA-MIR-548AN99.9770.912817
HSA-MIR-391099.9571.132227
HSA-MIR-539-5P99.9370.302855
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-205-3P99.9269.923165
HSA-MIR-95-5P99.8972.173973
HSA-MIR-629-3P99.8567.991875
HSA-MIR-129099.5969.902079
HSA-MIR-6716-5P99.5668.621244
HSA-MIR-5004-3P99.5468.271371
HSA-MIR-312399.4767.152693
HSA-MIR-522-3P98.9168.561817
HSA-MIR-3145-3P98.8569.072031
HSA-MIR-426098.7865.37848
HSA-MIR-5699-5P97.3667.031014
HSA-MIR-7161-3P96.7968.79798
HSA-MIR-5586-5P96.2968.02685

Cross-species orthologs

13 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-193c22.1ENSDARG00000093687
mus_musculusAadacl4fm1ENSMUSG00000028593
mus_musculusAAdacl4fm3ENSMUSG00000041735
mus_musculusAadacl4ENSMUSG00000070609
mus_musculusAadacl4fm5ENSMUSG00000078504
mus_musculusAadacl4fm4ENSMUSG00000078505
rattus_norvegicusAadacl4fm1ENSRNOG00000026782
rattus_norvegicusAAdacl4fm3l1ENSRNOG00000037027
rattus_norvegicusAadacl4ENSRNOG00000037030
rattus_norvegicusAAdacl4fm3ENSRNOG00000042808
caenorhabditis_elegansWBGENE00009186
caenorhabditis_elegansWBGENE00011642
caenorhabditis_elegansWBGENE00017515

Paralogs (5): AADAC (ENSG00000114771), NCEH1 (ENSG00000144959), AFMID (ENSG00000183077), AADACL3 (ENSG00000188984), AADACL2 (ENSG00000197953)

Protein

Protein identifiers

Arylacetamide deacetylase-like 4Q5VUY2 (reviewed: Q5VUY2)

All UniProt accessions (1): Q5VUY2

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the ‘GDXG’ lipolytic enzyme family.

RefSeq proteins (1): NP_001013652* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013094AB_hydrolase_3Domain
IPR017157Arylacetamide_deacetylaseFamily
IPR029058AB_hydrolase_foldHomologous_superfamily
IPR050300GDXG_lipolytic_enzymeFamily

Pfam: PF07859

UniProt features (10 total): active site 3, topological domain 2, glycosylation site 2, chain 1, transmembrane region 1, short sequence motif 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5VUY2-F196.050.94

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (3): 193; 347; 377

Glycosylation sites (2): 168, 269

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 9 (showing top): GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY, chr1p36, PEDRIOLI_MIR31_TARGETS_UP, MIR95_5P, MIR539_5P, MIR1290, MIR6716_5P, DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS

GO Biological Process (0):

GO Molecular Function (2): carboxylic ester hydrolase activity (GO:0052689), hydrolase activity (GO:0016787)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
hydrolase activity, acting on ester bonds1
catalytic activity1
cellular anatomical structure1

Protein interactions and networks

STRING

942 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
AADACL4RNF223E7ERA6623
AADACL4PRXL2CQ7RTV5488
AADACL4RNF148Q8N7C7422
AADACL4C9J5N1C9J5N1406
AADACL4TIFABQ6ZNK6400
AADACL4ELOF1P60002393
AADACL4AAGABQ6PD74388
AADACL4AAR2Q9Y312386
AADACL4AAMDCQ9H7C9372
AADACL4A4GNTQ9UNA3371
AADACL4QTRT2Q9H974370
AADACL4AARSD1Q9BTE6363
AADACL4TLX2O43763358
AADACL4ALDH5A1P51649348
AADACL4ABATP80404348

IntAct

2 interactions, top by confidence:

ABTypeScore
Ppsi-mi:“MI:0914”(association)0.350

ESM2 similar proteins: A2A7Z8, A7LB60, P08910, P0DKC5, P0DKC6, P22760, P70683, P83006, Q05AK6, Q0P5B7, Q13093, Q14032, Q1LZ86, Q28017, Q32LS6, Q4R2Y9, Q4V8A1, Q502J0, Q5EA42, Q5PPS7, Q5VUY0, Q5VUY2, Q5XI64, Q5ZJL8, Q5ZKL5, Q60963, Q63276, Q6DHN0, Q6GLL2, Q6IE26, Q6P093, Q7L211, Q7M370, Q7SY73, Q7Z5M8, Q802V6, Q80UX8, Q8BM81, Q8IUS5, Q8R2Y0

Diamond homologs: A2A7Z8, B2GV54, O53424, P15304, P16386, P22760, P54310, P95125, P9WK86, P9WK87, Q0P5B7, Q1JQE6, Q5R8Y5, Q5VUY0, Q5VUY2, Q68J42, Q6L545, Q6P093, Q6PIU2, Q7M370, Q8BLF1, Q8BM81, Q8KQK1, Q940G6, Q99PG0, Q9QZH8, A0A0H5BMX5, A0A2P1GIY2, A1A8E2, A7ZIN6, A7ZXD4, B1IZB8, B1LJN4, B1XFR3, B2U4S9, B5Z3Y7, B6I0B9, B7L7A1, B7M3W8, B7MDZ8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

79 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance64
Likely benign12
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
144297GRCh38/hg38 1p36.23-36.21(chr1:9064492-12666744)x1Pathogenic

SpliceAI

836 predictions. Top by Δscore:

VariantEffectΔscore
1:12644712:TTGG:Tdonor_loss0.9900
1:12644714:GGT:Gdonor_loss0.9900
1:12644715:G:GAdonor_loss0.9900
1:12644715:G:GGdonor_gain0.9900
1:12644716:TGAG:Tdonor_loss0.9900
1:12644717:GAGT:Gdonor_loss0.9900
1:12650376:ATT:Aacceptor_gain0.9900
1:12651337:TGGGT:Tdonor_loss0.9900
1:12651338:GG:Gdonor_gain0.9900
1:12651339:GG:Gdonor_gain0.9900
1:12651340:G:GCdonor_loss0.9900
1:12651341:T:TTdonor_loss0.9900
1:12664998:GCT:Gdonor_gain0.9900
1:12665956:TTTAG:Tacceptor_loss0.9900
1:12665957:TTA:Tacceptor_loss0.9900
1:12665960:G:GTacceptor_loss0.9900
1:12644673:T:Gdonor_gain0.9800
1:12644711:TTTG:Tdonor_gain0.9800
1:12650376:A:AGacceptor_gain0.9800
1:12650377:T:Gacceptor_gain0.9800
1:12651117:CAACA:Cacceptor_loss0.9800
1:12651120:CA:Cacceptor_loss0.9800
1:12651121:A:Tacceptor_loss0.9800
1:12651122:GGGGA:Gacceptor_gain0.9800
1:12651313:G:GTdonor_gain0.9800
1:12651331:G:GTdonor_gain0.9800
1:12651332:GAGCC:Gdonor_gain0.9800
1:12651340:G:GGdonor_gain0.9800
1:12665959:A:AGacceptor_gain0.9800
1:12665960:G:GGacceptor_gain0.9800

AlphaMissense

2666 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:12666538:A:CS343R0.987
1:12666540:C:AS343R0.987
1:12666540:C:GS343R0.987
1:12666088:A:CS193R0.938
1:12666090:C:AS193R0.938
1:12666090:C:GS193R0.938
1:12666590:T:CL360S0.930
1:12666679:T:CF390L0.928
1:12666681:C:AF390L0.928
1:12666681:C:GF390L0.928
1:12666587:G:CR359P0.922
1:12666560:G:CR350P0.921
1:12666637:T:CF376L0.917
1:12666639:T:AF376L0.917
1:12666639:T:GF376L0.917
1:12666028:T:CF173L0.915
1:12666030:C:AF173L0.915
1:12666030:C:GF173L0.915
1:12666536:T:AV342E0.915
1:12666029:T:CF173S0.914
1:12666160:G:CA217P0.910
1:12666562:G:CD351H0.909
1:12666391:T:CF294L0.906
1:12666393:T:AF294L0.906
1:12666393:T:GF294L0.906
1:12651294:G:CG114R0.901
1:12651123:G:AG57R0.897
1:12651123:G:CG57R0.897
1:12666568:A:CS353R0.894
1:12666570:C:AS353R0.894

dbSNP variants (sampled 300 via entrez): RS1000070273 (1:12662374 T>C), RS1000108427 (1:12643497 C>T), RS1000129460 (1:12665348 G>A), RS1000194867 (1:12665585 A>G), RS1000310995 (1:12665803 C>T), RS1000393608 (1:12660087 G>C), RS1000434004 (1:12654300 T>C,G), RS1000448152 (1:12648853 G>A,T), RS1000594952 (1:12643845 C>T), RS1000677548 (1:12661105 G>A), RS1000736960 (1:12659817 T>C), RS1000777134 (1:12655423 G>A), RS1000830161 (1:12655796 C>G), RS1000895024 (1:12660181 C>A,T), RS1001050888 (1:12644953 T>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST001762_123Obesity-related traits8.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
Acetaminophendecreases expression1
Benzo(a)pyreneincreases methylation1
Permethrindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.